NYMOX PHARMACEUTICAL CORPORATION Advances
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Advances of $3.29 million as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:Advances · last filed 2025-06-03
- 2024-12-31: Advances $3.29M.
- 2023-12-31: Advances $750.00K.
- 2022-12-31: Advances $0.00.
| Period end | Advances |
|---|---|
| 2024-12-31 | $3.29M 20-F · filed 2025-06-03 |
| 2023-12-31 | $750.00K 20-F · filed 2025-06-03 |
| 2022-12-31 | $0.00 20-F · filed 2024-08-29 |